Company Search:
Advanced Search
Sponsored Links
Astrazeneca Pharma India Ltd Company Snapshot
Astrazeneca Pharma India Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Astrazeneca Pharma India Ltd with three other companies in this sector in INDIA : Ind-Swift Laboratories Limited (2020 sales of 7.80 billion Indian Rupees [US$106.50 million] of which 100% was Bulk Drugs & Pharmaceuticals), Morepen Laboratories Limited (8.53 billion Indian Rupees [US$116.53 million] of which 100% was Pharmaceutical segment), and Caplin Point Laboratories Limited (8.63 billion Indian Rupees [US$117.91 million] of which 100% was Pharmaceuticals formulations).

Sales Analysis. During the year ended March of 2020, sales at Astrazeneca Pharma India Ltd were 8.32 billion Indian Rupees (US$113.63 million). This is an increase of 14.2% versus 2019, when the company's sales were 7.28 billion Indian Rupees . This was the third consecutive year of growth at Astrazeneca Pharma India Ltd.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Astrazeneca Pharma India Ltd
  Stock Performance Chart for Astrazeneca Pharma India Ltd
  Stock Data: Recent Stock Performance:
  Current Price (5/14/2021): 3,842.90
(Figures in Indian Rupees )
1 Week 0.9%   13 Weeks 11.2%  
4 Weeks 4.7%   52 Weeks 27.2%  
Astrazeneca Pharma India Ltd Key Data:
  Ticker: ASTRAZEN Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 8,318,100,000
(Year Ending Jan 2021).
Employees: 1,325
  Currency: Indian Rupees Market Cap: 96,072,500,000
  Fiscal Yr Ends: March Shares Outstanding: 25,000,000
  Share Type: Ordinary Closely Held Shares: 21,512,989
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.